Related Experiment Video

Updated: Feb 20, 2026

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology
09:33

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology

Published on: February 7, 2015

16.9K

Study of carotid intimal medial thickness in essential hypertension with or without left ventricular hypertrophy

Himanshu Khutan1, Simmi Aggarwal2, K S Kajal1

  • 1Department of Medicine, GGS Medical College and Hospital, Faridkot, Punjab, India.

Annals of African Medicine
|October 25, 2017
PubMed

Insights

Hypertension is linked to increased carotid intimal medial thickness (CIMT) and left ventricular hypertrophy (LVH). Managing hypertension should address both blood pressure and arterial wall changes for better patient outcomes.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Hypertension Research

Background:

  • Hypertension and atherosclerosis are distinct but interconnected conditions.
  • Hypertension significantly contributes to the development of atherosclerosis.
  • This study investigates the relationship between carotid intimal medial thickness and left ventricular hypertrophy in hypertensive individuals.

Purpose of the Study:

  • To examine the association between carotid intimal medial thickness (CIMT) and left ventricular hypertrophy (LVH).
  • To understand the implications for hypertensive patient management.

Main Methods:

  • A prospective observational study involving 100 hypertensive patients (JNC-7, Stage 1 and 2) aged 30-55 years.
  • Data collection included Electrocardiogram (ECG), Carotid Doppler, Echocardiography, and routine biochemical tests.
  • The study was conducted at a tertiary care teaching institute in Punjab, India.

Main Results:

  • Increased CIMT showed a significant association with age, hypertension duration, and high blood pressure (BP).
  • LVH and left ventricular mass index were also statistically linked to increased CIMT.
  • No significant association was found between CIMT and body mass index, low-density lipoproteins, or total cholesterol.

Conclusions:

  • Left ventricular hypertrophy (LVH) and arterial wall changes, such as increased CIMT, occur simultaneously in hypertensive patients.
  • Hypertension management should extend beyond blood pressure control to include therapies targeting carotid plaques and elevated CIMT.
  • Concurrent management of arterial wall changes alongside BP control is crucial for comprehensive hypertension care.
Abstract

More Related Videos

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.6K
Ultrasonic Assessment of Myocardial Microstructure10:53

Ultrasonic Assessment of Myocardial Microstructure

Published on: January 14, 2014

5.9K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
540
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
636
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
590
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.1K